Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1556/650.2021.32272 http://scihub22266oqcxt.onion/10.1556/650.2021.32272 34120104!ä!34120104 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Orv+Hetil 2021 ; 162 (24): 938-942 Nephropedia Template TP {{tp|p=34120104|t=2021. SARS-CoV-2-fertozes es COVID-19 Gaucher-koros betegekben: a vedooltas javallata |pdf=|usr=}}{{34120104}} gab.com Text SARS-CoV-2-fertozes es COVID-19 Gaucher-koros betegekben: a vedooltas javallata JO: Orv Hetil http://www.kidney.de/pget.php?&tw=1&pmid=34120104 #FOAvip At the start of the pandemic caused by the novel coronavirus (SARS-CoV-2), the Gaucher disease community anticipated that infection with this emerging viral pathogen would be associated with high morbidity and mortality in individuals with this chronic metabolic disorder. Surprisingly, however, preliminary studies suggest that Gaucher disease does not confer a higher risk of severe, life-threatening effects of SARS-CoV-2 infection, and no severe cases have been reported in large cohorts of patients from the United States, Europe and Israel. It is thought that the accumulation of glucocerebroside in the cells of Gaucher patients may promote immune tolerance rather than inflammation on exposure to SARS-CoV-2. We review here the current concepts of Gaucher disease and SARS-CoV-2 infection, focusing particularly on general prevention and vaccination. We also discuss the susceptibility to COVID-19 of patients with inborn errors of type 1 interferon (IFNalpha and IFNomega) immunity. Orv Hetil. 2021; 162(24): 938-942. Twit Text FOAVip SARS-CoV-2-fertozes es COVID-19 Gaucher-koros betegekben: a vedooltas javallata ????Orv Hetil http://www.kidney.de/pget.php?&tw=1&pmid=34120104 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34120104 #FOAvip English Wikipedia <ref>{{Cite pmid|34120104}}</ref> SARS-CoV-2-fertozes es COVID-19 Gaucher-koros betegekben: a vedooltas javallata #MMPMID34120104 Marodi L Orv Hetil 2021[Jun]; 162 (24): 938-942 PMID34120104show ga At the start of the pandemic caused by the novel coronavirus (SARS-CoV-2), the Gaucher disease community anticipated that infection with this emerging viral pathogen would be associated with high morbidity and mortality in individuals with this chronic metabolic disorder. Surprisingly, however, preliminary studies suggest that Gaucher disease does not confer a higher risk of severe, life-threatening effects of SARS-CoV-2 infection, and no severe cases have been reported in large cohorts of patients from the United States, Europe and Israel. It is thought that the accumulation of glucocerebroside in the cells of Gaucher patients may promote immune tolerance rather than inflammation on exposure to SARS-CoV-2. We review here the current concepts of Gaucher disease and SARS-CoV-2 infection, focusing particularly on general prevention and vaccination. We also discuss the susceptibility to COVID-19 of patients with inborn errors of type 1 interferon (IFNalpha and IFNomega) immunity. Orv Hetil. 2021; 162(24): 938-942. |*COVID-19[MESH] |*Gaucher Disease[MESH] |Europe[MESH] |Humans[MESH] |Male[MESH] |SARS-CoV-2[MESH]SARS-CoV-2-fertozes es COVID-19 Gaucher-koros betegekben: a vedooltas (epmc).pdf DeepDyve Pubget Overpricing